Replimune Group, Inc.
REPL
$12.06
-$0.80-6.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 34.43% | 60.09% | 70.22% | 54.05% | 22.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.50% | 35.56% | 38.62% | 24.90% | 11.60% |
| Operating Income | -22.50% | -35.56% | -38.62% | -24.90% | -11.60% |
| Income Before Tax | -27.41% | -38.44% | -45.71% | -27.27% | -14.60% |
| Income Tax Expenses | -217.74% | -181.96% | 14.71% | 126.09% | 14.71% |
| Earnings from Continuing Operations | -26.95% | -37.95% | -45.65% | -27.37% | -14.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.95% | -37.95% | -45.65% | -27.37% | -14.60% |
| EBIT | -22.50% | -35.56% | -38.62% | -24.90% | -11.60% |
| EBITDA | -23.09% | -37.47% | -39.60% | -25.22% | -11.48% |
| EPS Basic | -10.23% | -11.46% | -13.28% | 1.51% | 5.21% |
| Normalized Basic EPS | -10.64% | -11.82% | -13.33% | 1.59% | 5.22% |
| EPS Diluted | -10.23% | -11.46% | -13.28% | 1.51% | 5.21% |
| Normalized Diluted EPS | -10.64% | -11.82% | -13.33% | 1.59% | 5.22% |
| Average Basic Shares Outstanding | 15.54% | 23.39% | 27.71% | 28.44% | 20.66% |
| Average Diluted Shares Outstanding | 15.54% | 23.39% | 27.71% | 28.44% | 20.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |